Online exclusive: The dengue problem
Researchers set out to develop a dengue virus vaccine 80 years ago. We still don't have a good one.
Why we give: A tradition of American leadership
Dick and Karna Bodman establish a legacy at LJI
The many roads to LJI
A letter from LJI President and CEO Erica Ollmann Saphire, Ph.D.
Lessons from the funeral home
What high school student Livia Iacobelli learned from working in a hospital, a mortuary, and a laboratory during the pandemic
LJI works to level the playing field
New internship program is important step toward growing the careers of all scientists
Immunologic defect may leave some vulnerable to rare bacterial infection
LA JOLLA, CA—Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don’t get sick.
Discovering mechanisms of host cellular remodeling by viral pathogens with quantitative proteomics
Jeffery Johnson, PhD. Associate Professor, Icahn School of Medicine at Mount Sinai, Department of Microbiology
PD-L1/PD-1 Cancer Immunotherapy and New Targets
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan
The longer the bootcamp, the better the antibodies
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have discovered how the immune system can transform into an
Richard S. Bodman and Fred Miller join LJI Board of Directors
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) has welcomed Richard S. Bodman and Fred Miller to the Institute’s Board
How human cells become Zika virus factories
LA JOLLA, CA—Zika virus has a trick up its sleeve. Once inside the body, the virus likes to make a